Income Tax Expense (Benefit) in USD of Gossamer Bio, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Gossamer Bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to Q3 2025.
  • Gossamer Bio, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $0.000.
  • Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2024 was $893K.
  • Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)

Gossamer Bio, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 +$1.13M Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $0 -$4.44M -100% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q3 2024 -$1.13M -$1.13M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $4.44M +$4.44M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12

Gossamer Bio, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $893K +$893K Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2020-03-24
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.